New Gene Linked to Congenital Heart Defects

Researchers from the UC San Diego, School of Medicine and colleagues have identified a new gene, ETS-1, that is linked to human congenital heart defects. The landmark study, recently published online in the journal of Human Molecular Genetics, provides important insights into some of the most prevalent forms of congenital heart defects in humans, including Ventricular septal defects and potentially Hypoplastic left heart syndrome, a uniformly fatal heart abnormality.

“Identification of this gene may have implications for prevention of some of these most common types of congential heart defects,” said Paul Grossfeld, MD, associate professor of pediatrics for the UC San Diego School of Medicine and pediatric cardiologist for Rady Children’s Hospital-San Diego.

The researchers performed high-resolution chromosomal microarray mapping on human patients identified with the 11q- phenotype.

Through a combination of human genetics and functional studies in genetically engineered mice, the researchers were able to pinpoint ETS-1 as a gene for causing at least a subset of the heart defects that occur in 11q- and the general human population.

Characterized by a distinctive facial appearance, Jacobsen syndrome, also known as 11q terminal deletion disorder (11q-), is a rare chromosomal disorder resulting from the partial loss of one copy of human chromosome number 11. It is the loss of genes that leads to multiple clinical challenges associated with 11q- such as congenital heart disease, developmental and behavioral problems, low platelet counts, gastrointestinal, urinary and ophthalmologic abnormalities, failure to thrive and slow growth.

“Nearly 15 years ago, in my first month of pediatric cardiology training at UC San Diego, I came across my first patient with 11q-. To this day, I still care for this child,” said Grossfeld. “Since then, I have devoted my career to learning everything about this syndrome and hope that we have now more clearly defined the path to understanding, and perhaps preventing, some forms of congenital heart disease.”

This research was funded by grants from the National Institutes of Health, the State of South Dakota, and the Children’s Heart Institute Fund from Rady Children’s Hospital-San Diego.

Researchers involved in this study include Maoqing Ye, UC San Diego; Chris Coldren, University of Colorado Health Sciences Center; Xingqun Liang, UC San Diego, Teresa Mattina, University of Catania; Elizabeth Goldmuntz, Children’s Hospital of Philadelphia; D Woodrow Benson, Cincinnati Children’s Hospital; Dunbar Ivy, University of Colorado Health Sciences Center; MB Perryman, University of South Dakota; Lee Ann Garrett-Sinha, SUNY-Buffalo; and Paul Grossfeld, UC San Diego.

Source:  University of California, San Diego Health Sciences

RELATED STORIES:
Optimism about heart risks may be a good thing   Rochester-Led Study Leads to Recommendation for Use of Heart Failure Treatment Nationwide   Public defibrillators boost cardiac arrest survival   Health Care Delivery Fixes Somewhat Helpful in Heart Disease   Long-term safety of drug-coated stents questioned   Women more likely to die after heart attack   Impotence plus heart disease ups death risk: study   Imaging fat layer around heart can help predict disease   A New Beat in Heart Research   New heart valve replacement technologies offer hope for high-risk patients   Big hearts may mean trouble in cross-country skiers   Does happiness make for a healthy heart?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]